n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Pancreatic Neoplasms in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (38.10) | 18.2507 |
2000's | 13 (61.90) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartolozzi, C; Boggi, U; Boraschi, P; Del Chiaro, M; Donati, F; Faggioni, L; Falaschi, F; Gigoni, R; Salemi, S | 1 |
Függer, R; Grabenwöger, F; Novacek, G; Oettl, C; Ryan, JM; Schima, W; Schober, E; Wamser, P | 1 |
Függer, R; Schima, W | 1 |
Schima, W | 1 |
Aboalmaali, N; Hamoud, AK; Khan, MF; Usadel, KH; Vogl, TJ; Wullstein, C | 1 |
Cullingford, G; Edmunds, S; Fletcher, D; Marshall, M; Mendelson, R; Ramsay, D; Song, S; Yusoff, I; Zimmerman, M | 1 |
Boccuni, R; Brambilla, P; Del Maschio, A; Di Carlo, V; Nicoletti, R; Staudacher, C; Zanello, A | 1 |
Blake, M; Fischman, AJ; Hahn, PF; Kadavigere, R; Kalva, SP; Sahani, DV; Saini, S | 1 |
Eser, C; Eser, G; Karabacakoglu, A; Karakose, S; Kayacetin, E | 1 |
Bocchi, C; Corradi, D; De Filippo, M; Quartieri, L; Zompatori, M | 1 |
Gehl, HB; Günther, RW; Hauptmann, S; Klever, P | 1 |
Bohndorf, K; Gehl, HB; Günther, RW; Hauptmann, S; Klever, P; Lodemann, KP; Matern, S; Schumpelick, V; Urhahn, R | 1 |
Kettritz, U; Semelka, RC | 1 |
Ahlström, H; Gehl, HB | 1 |
Mayo-Smith, WW; McFarland, EG; Saini, S; Schima, W; Slater, GJ | 1 |
Wang, C | 1 |
Caseiro-Alves, F; Coffin, C; Diche, T; Kobeiter, H; Mahfouz, A; Mathieu, D; Rahmouni, A | 1 |
Diehl, SJ; Gaa, J; Georgi, M; Hoffmann, V; Lehmann, KJ; McGill, S | 1 |
Laméris, JS; Romijn, MG; Stoker, J; Torres, CG; van Eijck, CH; van Muiswinkel, JM | 1 |
Brambs, HJ; Klaus, H; Nüssle, K; Rieber, A; Tomczak, R | 1 |
Baum, U; Bautz, W; Dobritz, M; Fellner, FA; Klein, P; Lell, M; Nömayr, A; Papadopoulos, T | 1 |
5 review(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Pancreatic Neoplasms
Article | Year |
---|---|
Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT.
Topics: Contrast Media; Edetic Acid; Humans; Laparotomy; Magnetic Resonance Imaging; Neoplasm Staging; Pancreatic Neoplasms; Pyridoxal Phosphate; Tomography, Spiral Computed; Ultrasonography, Interventional | 2002 |
Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.
Topics: Contrast Media; Edetic Acid; Humans; Insulinoma; Laparoscopy; Magnetic Resonance Imaging; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate; Robotics | 2004 |
Contrast-enhanced MR imaging of the pancreas.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Organometallic Compounds; Pancreas; Pancreas Transplantation; Pancreatic Diseases; Pancreatic Neoplasms; Pentetic Acid; Pyridoxal Phosphate | 1996 |
Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
Topics: Acute Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Manganese; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Reference Values | 1997 |
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Preoperative Care; Pyridoxal Phosphate | 1999 |
6 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Pancreatic Neoplasms
Article | Year |
---|---|
[Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Chronic Disease; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1993 |
Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
Topics: Adenocarcinoma; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate | 1993 |
Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Neoplasms; Pyridoxal Phosphate | 1998 |
MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
Topics: Adult; Aged; Carcinoma, Ductal, Breast; Chronic Disease; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 1999 |
MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2000 |
MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2000 |
10 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Pancreatic Neoplasms
Article | Year |
---|---|
Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Secretin; Tomography, X-Ray Computed | 2009 |
Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2002 |
[Organ specific MRI contrast media in general practice].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasm Staging; Neoplasms; Organ Specificity; Oxides; Pancreatic Neoplasms; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, Spiral Computed | 2002 |
Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging.
Topics: Contrast Media; Edetic Acid; Endosonography; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Pyridoxal Phosphate; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Retrospective Studies; Sensitivity and Specificity | 2004 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Pyridoxal Phosphate; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2005 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate | 2006 |
Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.
Topics: Adenocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Edetic Acid; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pyridoxal Phosphate; Tomography, X-Ray Computed | 2007 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Body Water; Brain; Carcinoid Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Dose-Response Relationship, Drug; Edetic Acid; Female; Humans; Image Enhancement; Infusions, Intravenous; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Pyridoxal Phosphate; Safety; Sensitivity and Specificity; Time Factors | 1998 |
[MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
Topics: Ampulla of Vater; Biopsy, Needle; Common Bile Duct Neoplasms; Contrast Media; Edetic Acid; Humans; Image Enhancement; Magnetic Resonance Imaging; Pancreatic Neoplasms; Pancreatitis; Pyridoxal Phosphate; Sensitivity and Specificity | 2002 |